Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER Compliance Office Director Must Recuse Herself From Most Duties

This article was originally published in The Pink Sheet Daily

Executive Summary

HHS General Counsel determines that to prevent potential conflicts of interest Cynthia Schnedar must no longer handle substantive issues for compliance actions and policy.

Advertisement

Related Content

US FDA’s New Compliance Chief Donald Ashley Brings International Law Enforcement Experience
FDA Again Taps Compliance Director For Globalization Post
CDER’s New Compliance Director Sklamberg Brings Experience On Compounding Issues

Topics

Advertisement
UsernamePublicRestriction

Register

PS079076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel